Evidence map›Paper›PMID 24161135›Full record

ReviewExpert review of gastroenterology & hepatology2013

Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Nivedita Basu, Halcyon G Skinner, Kristin Litzelman, Russell Vanderboom, Esha Baichoo, Lisa A Boardman

Open access · greenAbstract readReview
In one paragraph

Review in Expert review of gastroenterology & hepatology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. The role of microRNAs in gallbladder cancer.Molecular and clinical oncology · 2016
    Article
  13. Review
  14. Article
  15. Article
  16. Anti-tumor activities of matrine and oxymatrine: literature review.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nivedita BasuDepartment of Medicine, Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Halcyon G Skinner
Kristin Litzelman
Russell Vanderboom
Esha Baichoo
Lisa A Boardman
Mayo Clinic · USUniversity of Wisconsin–Madison · US

Funding

PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
Telomere length, telomere maintenance genes and cancer riskR01CA132718 · NCI · MAYO CLINIC ROCHESTER · PI BOARDMAN, LISA ALLYN · 2008 to 2012
$2.6M
Time lapse to cancer: defining transition from polyp to colorectal cancer (PQ14)R01CA170357 · NCI · MAYO CLINIC ROCHESTER · PI BOARDMAN, LISA ALLYN · 2012 to 2016
$2.5M
NCI NIH HHS R0-1 CA132718NCI NIH HHS R01 CA132718NCI NIH HHS R0-1 CA 170357NCI NIH HHS R01 CA170357NIDDK NIH HHS P30 DK084567
6 · The paper itself

Abstract

Aberrations in telomere length and telomere maintenance contribute to cancer development. In this article, we review the basic principles of telomere length in normal and tumor tissue and the presence of the two main telomere maintenance pathways as they pertain to gastrointestinal tract cancer. Peripheral blood telomeres are shorter in patients with many types of gastrointestinal tract cancers. Telomere length in tumor DNA also appears to shorten early in cancer development. Tumor telomere shortening is often accompanied by telomerase activation to protect genetically damaged DNA from normal cell senescence or apoptosis, allowing immortalized but damaged DNA to persist. Alternative lengthening of telomeres is another mechanism used by cancer to maintain telomere length in cancer cells. Telomerase and alternative lengthening of telomeres activators and inhibitors may become important chemopreventive or chemotherapeutic agents as our understanding of telomere biology, specific telomere-related phenotypes and its relationship to carcinogenesis increases.

Indexed as

Telomere HomeostasisTelomere ShorteningAnimalsAntineoplastic AgentsBiomarkers, TumorCell Transformation, NeoplasticEnzyme InhibitorsGastrointestinal NeoplasmsGenetic Predisposition to DiseaseHumansMolecular Targeted TherapyPhenotypeRisk FactorsTelomeraseTelomereAntineoplastic AgentsBiomarkers, TumorEnzyme InhibitorsTelomeraseTERT protein, human

Identifiers

PMID24161135
PMCPMC3892561
OpenAlexW2140909375

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.